halopemide

Known as: N-(2-(4-(5-chloro-2-oxo-1-benzimidazolinyl)piperidino)ethyl)-p-fluorobenzamide 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1978-2018
01219782018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Halopemide, which was identified by HTS to inhibit phospholipase D2 (PLD2), provided the basis for an exploratory effort to… (More)
Is this relevant?
Review
2005
Review
2005
Halopemide is a new psychotropic agent, a structural analogue of the neuroleptics of the butyrophenone type but with different… (More)
  • figure I
  • figure 2
  • table I
  • table II
Is this relevant?
Review
1985
Review
1985
Halopemide is a new psychotropic agent, a structural analogue of the neuroleptics of the butyrophenone type but with different… (More)
Is this relevant?
1982
1982
Halopemide inhibits 3H-BZ binding to crude and washed rat forebrain membranes with IC50 values of 16-25 microM. Its putative… (More)
Is this relevant?
1981
1981
Oxiperomide and tiapride are dopamine receptor antagonists claimed to have “antidyskinetic” properties in animal models and in… (More)
  • table 1
Is this relevant?
1981
1981
Various dopamine receptor antagonists have divergent clinical and neurochemical properties. The relative ability of… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
1980
1980
The effects of halopemide on the release of 3H-serotonin, 3H-noradrenaline, 3H-acetylcholine and 3H-GABA from rat frontal… (More)
Is this relevant?
1979
1979
The influence of halopemide, a new psychotropic agent, and some putative metabolites on the uptake of 14C-5-HT into blood… (More)
Is this relevant?
1979
1979
Dynamic (solvent generated) cation-exchange systems for the separation of drugs and main metabolites derived from butyrophenone… (More)
Is this relevant?
1978
1978
Halopemide is a new psychotropic agent, structurally related to the neuroleptics of the butyrophenone type, but with a different… (More)
Is this relevant?